Skip to main content
XCUR
NASDAQ Life Sciences

10% Owner Exicure HiTron Inc. Sells $3.3M in XCUR Shares, Reducing Stake by Over 22%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$5.88
Mkt Cap
$37.478M
52W Low
$3.101
52W High
$15.91
52W Position info
90% above low
Off High info
63% below high
Rel. Volume
Market data snapshot near publication time

XCUR sits 90% above its 52-week low of $3.101.

Summary

A 10% owner, Exicure HiTron Inc., sold over $3.3 million worth of EXICURE, INC. common stock, representing a significant reduction of their holdings and a substantial portion of the company's market capitalization.


Key Events · Ownership and Investor Activity · XCUR

  • Significant Insider Sale

    Exicure HiTron Inc., a 10% owner, disposed of 741,272 shares of common stock for a total value of $3,335,724.

  • Substantial Stake Reduction

    The sale represents a significant portion of EXICURE, INC.'s market capitalization and a 22.24% reduction in Exicure HiTron Inc.'s total holdings.

  • Transaction Price Noted

    The shares were sold at a price of $4.50 per share on January 7, 2026, compared to today's stock price of $5.88.


Analysis · XCUR · Life Sciences

The sale of 741,272 shares by Exicure HiTron Inc., a 10% owner, for approximately $3.3 million is a highly significant event for EXICURE, INC. This transaction represents a substantial portion of the company's market capitalization and a significant 22% reduction in the reporting owner's total stake. While 10% owners often sell for portfolio rebalancing, the sheer size of this disposition suggests a loss of conviction or a strategic exit, which could exert downward pressure on the stock. Investors should note the significant capital outflow from a major shareholder.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XCUR was trading at $5.88 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $37.5M. The 52-week trading range was $3.10 to $15.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XCUR - Latest Insights

XCUR
Nov 16, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $1.08 info
Change: +$0.010 (+0.93%) info
Market Cap: $7.07M info
XCUR
Nov 10, 2026, 3:50 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $1.08 info
Change: -$0.0010 (-0.09%) info
Market Cap: $7.07M info
XCUR
Nov 10, 2026, 3:50 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $1.08 info
Change: -$0.0010 (-0.09%) info
Market Cap: $7.07M info
XCUR
Nov 02, 2026, 5:25 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $1.08 info
Change: +$0.020 (+2%) info
Market Cap: $7.07M info
XCUR
Sep 16, 2026, 10:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $1.08 info
Change: -$0.225 (-17%) info
Market Cap: $7.07M info